However, both CL4 and CL4-R APL cells express a low BCL2 level, although they show substantial differences in sensitivity to ATO (IC50 = 0.88 vs. 4.53 μM; [7]), suggesting that other mechanisms can induce resistance to ATO. The gene discussed is BCL2; the disease is acute promyelocytic leukemia.